Spark Therapeutics, Inc. (ONCE) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 374 transactions totaling $657.9M, demonstrating a bearish sentiment with -$642.0M in net insider flow. The most recent transaction on Dec 17, 2019 involved a transaction of 200 shares valued at $22.9K.
No significant insider buying has been recorded for ONCE in the recent period.
No significant insider selling has been recorded for ONCE in the recent period.
Based on recent SEC filings, insider sentiment for ONCE is bearish with an Insider Alignment Score of 1/100 and a net flow of -$642.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Spark Therapeutics, Inc. (ONCE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading ONCE stock, having executed 374 transactions in the past 90 days. The most active insider is Hospital Of Philadelphia Foundation Children's (Executive), who has made 13 transactions totaling $514.2M.
Get notified when executives and directors at ONCE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 17, 2019 | Joseph La Barge | Executive | Tender | 200 | $114.50 | $22.9K | |
| Dec 17, 2019 | Joseph La Barge | Executive | Tender | 50,193 | $114.50 | $5.7M | Large |
| Dec 17, 2019 | Altschuler Steven | Executive | Tender | 28,000 | $114.50 | $3.2M | Large |
| Dec 17, 2019 | Ekman Lars | Executive | Tender | 3,000 | $114.50 | $343.5K | |
| Dec 17, 2019 | Faga Daniel | Executive | Tender | 38,828 | $114.50 | $4.4M | Large |
| Dec 17, 2019 | A. High Katherine | Executive | Tender | 278,834 | $114.50 | $31.9M | Large |
| Dec 17, 2019 | D. Marrazzo Jeffrey | Executive | Tender | 355,215 | $114.50 | $40.7M | Large |
| Dec 17, 2019 | Mingozzi Federico | Executive | Tender | 12,615 | $114.50 | $1.4M | Large |
| Dec 17, 2019 | Mehra Anand | Executive | Tender | 481,270 | $114.50 | $55.1M | Large |
| Dec 17, 2019 | Mehra Anand | Executive | Tender | 40,203 | $114.50 | $4.6M | Large |
| Dec 17, 2019 | Milano Vincent | Executive | Tender | 3,000 | $114.50 | $343.5K | |
| Dec 17, 2019 | J. Perez Robert | Executive | Tender | 2,500 | $114.50 | $286.3K | |
| Dec 17, 2019 | Sigal Elliot | Executive | Tender | 14,214 | $114.50 | $1.6M | Large |
| Dec 17, 2019 | W. Webster Stephen | Executive | Tender | 6,102 | $114.50 | $698.7K | Large |
| Dec 17, 2019 | Dalton Lisa | Executive | Tender | 4,134 | $114.50 | $473.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 179 | $650.0M | 75.3% |
Tender(U) | 16 | $151.3M | 17.5% |
Payment(F) | 32 | $30.5M | 3.5% |
Exercise(M) | 132 | $23.4M | 2.7% |
Purchase(P) | 9 | $8.0M | 0.9% |
Award(A) | 1 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insider selling pressure at Spark Therapeutics, Inc. has increased, with 17 insiders executing 374 transactions across all time. Total sales of $650.0M significantly outpace purchases of $8.0M, resulting in a net outflow of $642.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.